arginyl-glycyl-aspartic acid has been researched along with Cirrhoses, Experimental Liver in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, SL; Li, F; Liu, M; Lu, WY; Shi, JY; Sun, JY; Wang, JY; Xie, C | 1 |
| Du, SL; Lu, WY; Pan, H; Wang, J; Wang, JY | 1 |
| Aeed, H; Barg, J; Bruck, R; Halpern, Z; Hershkoviz, R; Lider, O; Matas, Z; Zaidel, L | 1 |
| Aeed, H; Bruck, R; Halpern, Z; Hershkoviz, R; Lider, O; Shirin, H | 1 |
1 review(s) available for arginyl-glycyl-aspartic acid and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Non-peptidic analogs of the cell adhesion motif RGD prevent experimental liver injury.
Topics: Animals; Carcinogens; Concanavalin A; Disease Progression; Guanidines; Hepatitis, Autoimmune; Liver Cirrhosis, Experimental; Mice; Mitogens; Oligopeptides; Rats; Receptors, Immunologic; T-Lymphocytes; Thioacetamide; Transaminases; Tumor Necrosis Factor-alpha; Valerates | 2000 |
3 other study(ies) available for arginyl-glycyl-aspartic acid and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Effect of hepatocyte growth factor encapsulated in targeted liposomes on liver cirrhosis.
Topics: Animals; Apoptosis; Collagen Type I; Collagen Type I, alpha 1 Chain; Drug Carriers; Hepatocyte Growth Factor; Hydroxyproline; Liposomes; Liver; Liver Cirrhosis, Experimental; Maleimides; Oligopeptides; Phosphatidylethanolamines; Polyethylene Glycols; Rats | 2008 |
[Antifibrotic effects of cyclic RGD-peptide mediated liposomal interferon: an experimental on rats].
Topics: Actins; Animals; Collagen Type I; Interferon Type I; Liposomes; Liver Cirrhosis, Experimental; Liver Function Tests; Male; Oligopeptides; Peptides, Cyclic; Random Allocation; Rats; Rats, Sprague-Dawley; Recombinant Proteins; RNA, Messenger | 2005 |
Inhibition of experimentally-induced liver cirrhosis in rats by a nonpeptidic mimetic of the extracellular matrix-associated Arg-Gly-Asp epitope.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Biopsy; Carcinogens; Cell Adhesion; Disease Progression; Extracellular Matrix; Female; Fibronectins; Guanidines; Hemodynamics; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Oligopeptides; Rats; Rats, Wistar; Spleen; Thioacetamide; Valerates | 1996 |